Literature DB >> 20052801

Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.

Zhiqiang Qin1, Patricia Kearney, Karlie Plaisance, Chris H Parsons.   

Abstract

Macrophages are an important source of inflammatory cytokines generated during the innate immune response,but in the microenvironment of certain tumors,macrophages promote tumor progression through their preferential secretion of cytokines that support tumor cell growth and suppress antitumoral immune responses. KSHV is the causative agent of KS and lymphomas preferentially arising in immuno compromised patients, and specific cytokines, including IL-6 and IL-10, have been implicated in KSHV-associated cancer pathogenesis. However, the contribution of KSHV-infected macrophages to the cytokine milieu within KSHV-related tumors is unclear. We found that individual KSHV-encoded miRNA induce IL-6 and IL-10 secretion independently and additively by murine macrophages and human myelomonocytic cells. Bioinformatics analysis identified KSHV miRNA binding sites formiR-K12-3 and miR-K12-7 within the 3'UTR of the basic region/leucine zipper motif transcription factor C/EBPbeta, a known regulator of IL-6 and IL-10 transcriptional activation.Subsequent immunoblot analyses revealed that miR-K12-3 and miR-K12-7 preferentially reduce expression of C/EBPbeta p20 (LIP), an isoform of C/EBPbeta known to function as a negative transcription regulator. In addition,RNA interference specifically targeting LIP induced basal secretion of IL-6 and IL-10 by macrophages.Taken together, these data support a role for KSHV miRNA in the programming of macrophage cytokine responses in favor of KSHV-related tumor progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20052801      PMCID: PMC2801620          DOI: 10.1189/jlb.0409251

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  58 in total

1.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

2.  Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.

Authors:  Shiou-Hwa Jee; Chia-Yu Chu; Hien-Ching Chiu; Yi-Ling Huang; Wei-Ling Tsai; Yi-Hua Liao; Min-Liang Kuo
Journal:  J Invest Dermatol       Date:  2004-12       Impact factor: 8.551

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.

Authors:  H G Drexler; C Meyer; G Gaidano; A Carbone
Journal:  Leukemia       Date:  1999-04       Impact factor: 11.528

5.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

6.  Identification of microRNAs of the herpesvirus family.

Authors:  Sébastien Pfeffer; Alain Sewer; Mariana Lagos-Quintana; Robert Sheridan; Chris Sander; Friedrich A Grässer; Linda F van Dyk; C Kiong Ho; Stewart Shuman; Minchen Chien; James J Russo; Jingyue Ju; Glenn Randall; Brett D Lindenbach; Charles M Rice; Viviana Simon; David D Ho; Mihaela Zavolan; Thomas Tuschl
Journal:  Nat Methods       Date:  2005-02-16       Impact factor: 28.547

7.  gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages.

Authors:  M C Sirianni; L Vincenzi; V Fiorelli; S Topino; E Scala; S Uccini; A Angeloni; A Faggioni; D Cerimele; F Cottoni; F Aiuti; B Ensoli
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

8.  Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions.

Authors:  Y Aoki; R Yarchoan; J Braun; A Iwamoto; G Tosato
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

9.  Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

Authors:  K D Jones; Y Aoki; Y Chang; P S Moore; R Yarchoan; G Tosato
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

10.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

View more
  82 in total

1.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

Review 2.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

3.  Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiqiang Qin; Lu Dai; Bryan Toole; Erle Robertson; Chris Parsons
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.

Authors:  Zheng Xu; Shao-Bo Xiao; Peng Xu; Qian Xie; Lu Cao; Dang Wang; Rui Luo; Yao Zhong; Huan-Chun Chen; Liu-Rong Fang
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

5.  MicroRNAs control herpesviral dormancy.

Authors:  Xiufen Lei; Zhiqiang Bai; Fengchun Ye; Yufei Huang; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

Review 6.  Viral miRNAs: tools for immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Curr Opin Microbiol       Date:  2010-06-25       Impact factor: 7.934

7.  An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors:  Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

8.  MicroRNA expression profiles in Kaposi's sarcoma.

Authors:  Ana Maria Catrina Ene; Ioana Borze; Mohamed Guled; Mariana Costache; Gayle Leen; Maria Sajin; Elena Ionica; Aura Chitu; Sakari Knuutila
Journal:  Pathol Oncol Res       Date:  2013-09-13       Impact factor: 3.201

9.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.